Tumor suppressor function of Rab25 in triple-negative breast cancer

被引:80
作者
Cheng, Ji-Ming [1 ,2 ]
Volk, Lisa [2 ,3 ]
Janaki, Deepak Kumar Mummidavarapu [4 ]
Vyakaranam, Sudhir [5 ]
Ran, Sophia [2 ,3 ]
Rao, Krishna A. [1 ,2 ,3 ]
机构
[1] So Illinois Univ, Sch Med, Div Hematol & Oncol, Dept Internal Med, Springfield, IL 62794 USA
[2] SimmonsCooper Canc Inst SIU, Springfield, IL USA
[3] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA
[4] Univ Illinois Coll Med Peoria, Dept Internal Med, Peoria, IL USA
[5] Univ Cincinnati, Div Nephrol, Cincinnati, OH USA
关键词
mammary neoplasia; Rab25; p21; RAS; tumorigenesis; apoptosis; ENDOTHELIAL GROWTH-FACTOR; FACTOR VEGF FAMILY; EXPRESSION; CELLS; SPECIFICITY; APOPTOSIS; PATHWAY; MEMBERS; OVARIAN;
D O I
10.1002/ijc.24900
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rab proteins are a group of ubiquitously expressed proteins that are responsible for intracellular transport of vesicles. Recent evidence has shown that certain Rab proteins are involved in the pathogenesis of cancer. We have recently shown that Rab25 is lost in a large fraction of breast cancer samples, particularly those derived from hormonally insensitive tumors. We have further investigated the role of Rab25 by re-expressing Rab25 in tumorigenic cell lines and measuring the impact on tumor formation as well as on various molecular pathways through PCR array analysis. In vivo tumor growth of cell lines with re-expressed Rab25 was markedly suppressed. Our data suggest that Rab25 acts through multiple pathways to enhance apoptosis and to suppress angiogenesis and invasion by modulating VEGF-A and VEGFR-1 expression. These findings suggest that Rab25 represents a novel class of cellular modulators that can influence both tumor initiation and the progression of the established tumors, thus ultimately affecting the biology of the malignant disease.
引用
收藏
页码:2799 / 2812
页数:14
相关论文
共 38 条
[1]   Characterization of human Rab20 overexpressed in exocrine pancreatic carcinoma [J].
Amillet, JM ;
Ferbus, D ;
Real, FX ;
Antony, C ;
Muleris, M ;
Gress, TM ;
Goubin, G .
HUMAN PATHOLOGY, 2006, 37 (03) :256-263
[2]  
BAND V, 1990, CANCER RES, V50, P7351
[3]   A genomic perspective on membrane compartment organization [J].
Bock, JB ;
Matern, HT ;
Peden, AA ;
Scheller, RH .
NATURE, 2001, 409 (6822) :839-841
[4]   Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments [J].
Caswell, Patrick T. ;
Spence, Heather J. ;
Parsons, Maddy ;
White, Dominic P. ;
Clark, Katherine ;
Cheng, Kwai Wa ;
Mills, Gordon B. ;
Humphries, Martin J. ;
Messent, Anthea J. ;
Anderson, Kurt I. ;
McCaffrey, Mary W. ;
Ozanne, Bradford W. ;
Norman, Jim C. .
DEVELOPMENTAL CELL, 2007, 13 (04) :496-510
[5]   rab7 activity affects epidermal growth factor: Epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome [J].
Ceresa, BP ;
Bahr, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) :1099-1106
[6]   LOCALIZATION OF LOW-MOLECULAR-WEIGHT GTP BINDING-PROTEINS TO EXOCYTIC AND ENDOCYTIC COMPARTMENTS [J].
CHAVRIER, P ;
PARTON, RG ;
HAURI, HP ;
SIMONS, K ;
ZERIAL, M .
CELL, 1990, 62 (02) :317-329
[7]   Loss of RAB25 expression in breast cancer [J].
Cheng, Ji-Ming ;
Ding, Ming ;
Aribi, Ahmed ;
Shah, Prabodh ;
Rao, Krishna .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) :2957-2964
[8]   The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers [J].
Cheng, KW ;
Lahad, JP ;
Kuo, WL ;
Lapuk, A ;
Yamada, K ;
Auersperg, N ;
Liu, JS ;
Smith-McCune, K ;
Lu, KH ;
Fishman, D ;
Gray, JW ;
Mills, GB .
NATURE MEDICINE, 2004, 10 (11) :1251-1256
[9]   Triple-negative breast cancer: therapeutic options [J].
Cleator, Susan ;
Heller, Wolfgang ;
Coombes, R. Charles .
LANCET ONCOLOGY, 2007, 8 (03) :235-244
[10]   OVERPRODUCTION OF P53 ANTIGEN MAKES ESTABLISHED CELLS HIGHLY TUMORIGENIC [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
OREN, M .
NATURE, 1985, 316 (6024) :158-160